ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,33 € ↑0,20 (3,26%)
2026-06-04
DELAT PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionSculptor Capital LP
ManagerDaniel Och
Latest Disclosed Ownership89,200 shares
Latest Disclosed Value $ 684,164
Sculptor Capital LP ownership in 26CA / ImmunityBio, Inc.

On May 15, 2026 - Sculptor Capital LP filed a 13F-HR form disclosing ownership of 89,200 shares of ImmunityBio, Inc. (DE:26CA) valued at $585,152 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 619,000 shares of ImmunityBio, Inc.. This represents a change in shares of -85.59% during the quarter. The current value of the position is $564,636 USD.

Sculptor Capital LP has a history of taking positions in derivatives of the underlying security (26CA) in the form of stock options. The firm currently holds call options representing 100,000 of underlying shares valued at $767,000 USD and put options representing 89,200 of underlying shares valued at $684,164 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:26CA / ImmunityBio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM 45256X103 89,200 -529,800 -85.59 684 -44.16 0.0071
2026-02-13 2025-12-31 13F IMMUNITYBIO COM 45256X103 619,000 0 0.00 1,226 -19.51 0.0126
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 619,000 310,400 100.58 1,523 86.98 0.0180
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 308,600 308,600 815 0.0115
2026-02-26 2025-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 0 -270,800 -100.00 0 -100.00
2025-05-15 2025-03-31 13F IMMUNITYBIO COM 45256X103 0 -270,800 0
2025-02-14 2024-12-31 13F IMMUNITYBIO COM 45256X103 270,800 53,000 24.33 693 -14.44 0.0092
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 217,800 95,300 77.80 810 4.65 0.0138
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 122,500 -143,700 -53.98 774 -45.84 0.0146
2024-05-15 2024-03-31 13F IMMUNITYBIO COM 45256X103 266,200 186,700 234.84 1,429 258.15 0.0279
2024-02-14 2023-12-31 13F IMMUNITYBIO COM 45256X103 79,500 -51,800 -39.45 399 80.54 0.0084
2023-11-14 2023-09-30 13F IMMUNITYBIO COM 45256X103 131,300 0 0.00 222 -39.45 0.0045
2023-08-14 2023-06-30 13F IMMUNITYBIO COM 45256X103 131,300 82,100 166.87 365 310.11 0.0072
2023-05-16 2023-03-31 13F IMMUNITYBIO COM 45256X103 49,200 0 0.00 90 -64.26 0.0020
2023-02-14 2022-12-31 13F IMMUNITYBIO COM 45256X103 49,200 0 0.00 249 1.63 0.0044
2022-11-14 2022-09-30 13F IMMUNITYBIO COM 45256X103 49,200 49,200 245 0.0031
2022-05-20 2022-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 0 -153,300 -100.00 0 -100.00
2022-05-13 2022-03-31 13F IMMUNITYBIO COM 45256X103 0 -153,300 0
2022-02-11 2021-12-31 13F IMMUNITYBIO COM 45256X103 153,300 -4,800 -3.04 932 -39.48 0.0079
2021-11-12 2021-09-30 13F IMMUNITYBIO COM 45256X103 158,100 0 0.00 1,540 -31.80 0.0127
2021-08-16 2021-06-30 13F IMMUNITYBIO COM 45256X103 158,100 0 0.00 2,258 -39.83 0.0164
2021-08-16 2021-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 158,100 151,300 2,225.00 3,753 4,024.18 0.0307
2021-05-14 2021-03-31 13F IMMUNITYBIO COM 45256X103 158,100 151,300 3,753 0.0307
2021-02-16 2020-12-31 13F NANTKWEST COM 63016Q102 6,800 6,800 91 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM Call 100,000 767 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNITYBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNITYBIO COM Call 610,000 1,050.94 1,610 912.58 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNITYBIO COM Call 53,000 160 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNITYBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNITYBIO COM Call 200,000 -43.66 744 -66.83 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNITYBIO COM Call 355,000 42.00 2,244 67.14 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNITYBIO COM Call 250,000 1,342 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM Put 89,200 -85.61 684 -44.25 n/a n/a n/a
2026-02-13 2025-12-31 13F IMMUNITYBIO COM Put 620,000 0.00 1,228 -19.54 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNITYBIO COM Put 620,000 0.00 1,525 -6.78 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNITYBIO COM Put 620,000 1,069.81 1,637 928.93 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNITYBIO COM Put 53,000 -80.50 160 -77.12 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNITYBIO COM Put 271,800 24.22 696 -14.51 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNITYBIO COM Put 218,800 0.00 814 -41.17 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNITYBIO COM Put 218,800 -17.81 1,383 -3.29 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNITYBIO COM Put 266,200 1,429 n/a n/a n/a
2024-02-14 2023-12-31 13F IMMUNITYBIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F IMMUNITYBIO COM Put 131,300 0.00 222 -39.45 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNITYBIO COM Put 131,300 166.87 365 310.11 n/a n/a n/a
2023-05-16 2023-03-31 13F IMMUNITYBIO COM Put 49,200 0.00 90 -64.26 n/a n/a n/a
2023-02-14 2022-12-31 13F IMMUNITYBIO COM Put 49,200 0.00 249 1.63 n/a n/a n/a
2022-11-14 2022-09-30 13F IMMUNITYBIO COM Put 49,200 245 n/a n/a n/a
2022-05-20 2022-03-31 13F/A IMMUNITYBIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-13 2022-03-31 13F IMMUNITYBIO COM Put 0 0 n/a n/a n/a
2022-02-11 2021-12-31 13F IMMUNITYBIO COM Put 153,300 0.00 932 -37.58 n/a n/a n/a
2021-11-12 2021-09-30 13F IMMUNITYBIO COM Put 153,300 0.00 1,493 -31.80 n/a n/a n/a
2021-08-16 2021-06-30 13F IMMUNITYBIO COM Put 153,300 -3.04 2,189 -41.67 n/a n/a n/a
2021-08-16 2021-03-31 13F/A IMMUNITYBIO COM Put 158,100 2,225.00 3,753 4,024.18 n/a n/a n/a
2021-05-14 2021-03-31 13F IMMUNITYBIO COM Put 158,100 3,753 n/a n/a n/a
2021-02-16 2020-12-31 13F NANTKWEST COM Put 6,800 91 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.